Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Survival Prediction In Mesothelioma Using A Scalable Lasso Regression Model: Instructions For Use And Initial Performance Using Clinical Predictors
A. Kidd, M. McGettrick, S. Tsim, D. Halligan, M. Bylesjo, K. Blyth
Published 2018 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Introduction Accurate prognostication is difficult in malignant pleural mesothelioma (MPM). We developed a set of robust computational models to quantify the prognostic value of routinely available clinical data, which form the basis of published MPM prognostic models. Methods Data regarding 269 patients with MPM were allocated to balanced training (n=169) and validation sets (n=100). Prognostic signatures (minimal length best performing multivariate trained models) were generated by least absolute shrinkage and selection operator regression for overall survival (OS), OS <6 months and OS <12 months. OS prediction was quantified using Somers DXY statistic, which varies from 0 to 1, with increasing concordance between observed and predicted outcomes. 6-month survival and 12-month survival were described by area under the curve (AUC) scores. Results Median OS was 270 (IQR 140–450) days. The primary OS model assigned high weights to four predictors: age, performance status, white cell count and serum albumin, and after cross-validation performed significantly better than would be expected by chance (mean DXY0.332 (±0.019)). However, validation set DXY was only 0.221 (0.0935–0.346), equating to a 22% improvement in survival prediction than would be expected by chance. The 6-month and 12-month OS signatures included the same four predictors, in addition to epithelioid histology plus platelets and epithelioid histology plus C-reactive protein (mean AUC 0.758 (±0.022) and 0.737 (±0.012), respectively). The <6-month OS model demonstrated 74% sensitivity and 68% specificity. The <12-month OS model demonstrated 63% sensitivity and 79% specificity. Model content and performance were generally comparable with previous studies. Conclusions The prognostic value of the basic clinical information contained in these, and previously published models, is fundamentally of limited value in accurately predicting MPM prognosis. The methods described are suitable for expansion using emerging predictors, including tumour genomics and volumetric staging.
This paper references
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.
P. Ruffié (1989)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
N. Vogelzang (2003)
Pretreatment Serum C-Reactive Protein Levels Predict Benefit From Multimodality Treatment Including Radical Surgery in Malignant Pleural Mesothelioma: A Retrospective Multicenter Analysis
B. Ghanim (2012)
Socioeconomic Inequalities in Lung Cancer Treatment: Systematic Review and Meta-Analysis
L. Forrest (2013)
Cyclooxygenase-2 expression predicts survival in malignant pleural mesothelioma.
S. O'Kane (2005)
Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis.
M. Baud (2013)
North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study
R. Gill (2016)
Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B.
J. Herndon (1998)
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation
H. Pass (2016)
Scottish Index of Multiple Deprivation ( SIMD )
Survival of pleural malignant mesothelioma in Italy: A population‐based study
F. Montanaro (2009)
Patterns of care for malignant pleural mesothelioma patients compensated by the Dust Diseases Board in New South Wales, Australia
S. C.-H. Kao (2013)
Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes
Anthony Linton (2017)
Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression
H. Yang (2015)
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
P. Rothwell (2012)
Deconvolution Estimation in Measurement Error Models: The R Package decon.
X. Wang (2011)
Health-related quality of life and inflammatory markers in malignant pleural mesothelioma
S. Kao (2012)
Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma
Zhou-Hong Yao (2014)
Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries.
J. Dalstra (2005)
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
M. Proctor (2011)
Applied Logistic Regression.
A. Scott (1991)
Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems
J. Edwards (2000)
Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent.
Noah Simon (2011)
On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.
H. Uno (2011)
Analysis of survival of mesothelioma cases in the Italian register (ReNaM).
A. Marinaccio (2003)
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
G. Collins (2015)
Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.
D. Curran (1998)
Predicting survival in malignant mesothelioma
A. Musk (2011)
Relationship between prognosis and neutrophil: lymphocyte and platelet:lymphocyte ratios in patients with malignant pleural mesotheliomas.
Y. Cihan (2014)
Regularization Paths for Generalized Linear Models via Coordinate Descent.
J. Friedman (2010)
Factors influencing long-term survival in mesothelioma patients—results of the German mesothelioma register
V. Neumann (2004)
Population-based survival for malignant mesothelioma after introduction of novel chemotherapy
R. Damhuis (2011)
A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis
F. Brims (2016)
A Patient-Centered Methodology That Improves the Accuracy of Prognostic Predictions in Cancer
M. Kashani-Sabet (2013)
Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan.
S. Nojiri (2011)
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
M. Charlson (1987)
Assessing the generalizability of prognostic information.
A. Justice (1999)
High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy
S. Kao (2010)
Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review.
L. Lee (2011)
Regularization and variable selection via the elastic net
H. Zou (2005)
lordif: An R Package for Detecting Differential Item Functioning Using Iterative Hybrid Ordinal Logistic Regression/Item Response Theory and Monte Carlo Simulations.
S. W. Choi (2011)
Regression Shrinkage and Selection via the Lasso
R. Tibshirani (1996)
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
G. Zalcman (2016)
Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma?
T. Frauenfelder (2011)
Prognostication and monitoring of mesothelioma using biomarkers: a systematic review
D. Arnold (2017)
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
R. Bueno (2016)
Survival patterns for malignant mesothelioma: The seer experience
R. Spirtas (1988)
This paper is referenced by
A nomogram to predict mechanical ventilation in Guillain‐Barré syndrome patients
Ping-ping Ning (2020)
lncRNA DLEU2 acts as a miR-181a sponge regulated SEPP1 (may as a biomarker for sarcopenia) to inhibit skeletal muscle differentiation and regeneration
Yao Wang (2020)
A Nomogram for Individual Prediction of Poor Prognosis After Radical Surgery in Patients with Primary Pancreatic Duct Adenocarcinoma
Shuyu Zhai (2020)
Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram
H. Wang (2018)
Predicting the Poor Recovery Risk of Aneurysmal Subarachnoid Hemorrhage: Clinical Evaluation and Management Based on a New Predictive Nomogram
Y. Yan (2021)
Prognostic model of patients with liver cancer based on tumor stem cell content and immune process
Weikaixin Kong (2020)
Development and validation a nomogram for predicting the risk of severe COVID-19: A multi-center study in Sichuan, China
Yiwu Zhou (2020)
Predicting Risk of Insulin Resistance in a Chinese Population with Polycystic Ovary Syndrome: Designing and Testing a New Predictive Nomogram
F. Jiang (2020)
Prognostic implications of autophagy-associated gene signatures in non-small cell lung cancer
Y. Liu (2019)
RETRACTED ARTICLE: The diagnostic nomogram of platelet-based score models for hepatic alveolar echinococcosis and atypical liver cancer
Qiancheng Du (2019)
A prediction modeling based on SNOT-22 score for endoscopic nasal septoplasty: a retrospective study
Xue-ran Kang (2020)
Predicting Selection Preference of Robotic Pancreaticoduodenectomy (RPD) in a Chinese Single Center Population: Development and Assessment of a New Predictive Nomogram
Z. Huo (2019)
Retraction Note: The diagnostic nomogram of platelet-based score models for hepatic alveolar echinococcosis and atypical liver cancer
Qiancheng Du (2020)
Factors associated with the resilience of Tibetan adolescent survivors five years after the 2010 Yushu earthquake
Y. Lu (2020)
Predicting the risk of sarcopenia in elderly patients with patellar fracture: Development and assessment of a new predictive nomogram
Chen Yi-sheng (2019)
Helen: Maliciously Secure Coopetitive Learning for Linear Models
Wenting Zheng (2019)
Development and Internal Validation of a Nomogram to Predict Post-Stroke Fatigue After Discharge.
Ya Su (2020)
Novel Model Predicts Diabetic Nephropathy in Type 2 Diabetes
S. Jiang (2019)
Coopetitive Learning for Linear Models
Wenting Zheng (2019)
Prognostic Value of a Ten-Gene Signature in HNSCC Patients Based on Tumor-Associated Macrophages Expression Profiling
Zhao-yi Lu (2020)
Predicting the risk of sarcopenia in elderly patients with patellar fracture: development and assessment of a new predictive nomogram
Y. Chen (2020)
Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients
Z. Zhang (2020)
MiR-1908/EXO1 and MiR-203a/FOS, regulated by scd1, are associated with fracture risk and bone health in postmenopausal diabetic women
Y. Chen (2020)
Sharing without Showing: Building Secure Collaborative Systems
Wenting Zheng (2020)
Identification of key genes and pathways in obstructive coronary artery disease by integrated analysis
J. Li (2020)
Primary Tumor Resection Improves Survival in Patients With Metastatic Gastrointestinal Stromal Tumors: A Preliminary Population-Based Analysis
S. Zhao (2020)
Nomogram to predict successful smoking cessation in a Chinese outpatient population
N. Zhu (2020)
A prediction nomogram for the 3-year risk of incident diabetes among Chinese adults
Yang Wu (2020)
Dosimetry of Submandibular Glands on Xerostomia for Nasopharyngeal Carcinoma
Xinbin Pan (2020)
Exploiting an early warning Nomogram for predicting the risk of ICU admission in patients with COVID-19: a multi-center study in China
Yiwu Zhou (2020)
Development and validation of a nomogram for preoperative prediction of cervical lymph node involvement in thyroid microcarcinoma
S. Lu (2020)
Clinicopathological Characteristics and Prognosis of Nasopharyngeal Lymphoepithelial Carcinoma: A Population-Based Retrospective Study
Liu Xizhi (2020)See more